1.Babor T, Caulkins J, Fischer B, Foxcroft D,
Humphreys K, Medina-Mora M, et al. Drug policy
and the public good. 1 ed. New York: Oxford
University Press; 2010.
2.Ehsanpour SR, Rezaee R, Alahbedashti N. A new
classification of drugs, based on Comparative study.
Med L J. 2010;4(14):87-99.
3.Direkvand Moghadam A. The prevalence and
tendency causes of drug abuse among students in in
Ilam university of medical scincess during 2019.
Technol Res Inf Syst. 2021;3(4):0-.
4.Moghanibashi‐Mansourieh A, Deilamizade A. The
state of data collection on addiction in I ran. Addict.
2014;109(5):854-.
5.Moradinazar M, Najafi F, Jalilian F, Pasdar Y,
Hamzeh B, Shakiba E, et al. Prevalence of drug use,
alcohol consumption, cigarette smoking and measure
of socioeconomic-related inequalities of drug use
among Iranian people: findings from a national
survey. Subst Abuse Treat Prev Policy. 2020;15:1-11.
6.Shahbazi F, Mirtorabi D, Ghadirzadeh MR, Shojaei A,
Nazari SSH. Years of life lost (YLL) due to substance
abuse in Iran, in 2014-2017: Global Burden of Disease
2010 method. Iran J Public Health. 2020;49(11):2170.
7.GBD. Global, regional, and national incidence,
prevalence, and years lived with disability for 354
diseases and injuries for 195 countries and territories,
1990-2017: a systematic analysis for the Global
Burden of Disease Study 2017. Lancet.
2018;392(10159):1789-858.
8.Ghavidel N, Samadi M, Kharmanbiz A, Asadi A,
Feyzi A, Ahmadi R, et al. Investigation of substance
use prevalence and the interrelated factors involved
through third-year high school students in Nazarabad
city from January 2008 to June 2008. Razi J Med Sci.
2012;19(97):28-36.
9.Mohammadi TM, Hasheminejad N, Salari HR,
Rostamizadeh MR, Najafipour H. Association
between tooth loss and opium addiction: Results of a
community-based study on 5900 adult individuals in
South East of Iran in 2015. J Int Soc Prev Community
Dent. 2017;7(4):186-90.
10.Frishman WH, Del Vecchio A, Sanal S, Ismail A.
Cardiovascular manifestations of substance abuse:
part 2: alcohol, amphetamines, heroin, cannabis, and
caffeine. Heart Dis. 2003;5(4):253-71.
11.Martiniuk AL, Lee C, Lam T, Huxley R, Suh I,
Jamrozik K, et al. The fraction of ischaemic heart
disease and stroke attributable to smoking in the WHO
Western Pacific and South-East Asian regions. Tob
Control. 2006;15(3):181-8.
12.Radke JB, Owen KP, Sutter ME, Ford JB, Albertson
TE. The effects of opioids on the lung. Clin Rev
Allergy Immunol. 2014;46:54-64.
13.Martiniuk A, Lee CM, Woodward M, Huxley R.
Burden of lung cancer deaths due to smoking for men
and women in the WHO Western Pacific and South
East Asian regions. Asian Pac J Cancer Prev.
2010;11(1):67-70.
14.Saini GK, Gupta N, Prabhat K. Drug addiction and
periodontal diseases. J Indian Soc Periodontol.
2013;17(5):587-91.
15.Shahraki G, Sedaghat Z, Fararouei M. Family and
social predictors of substance use disorder in Iran: a
case-control study. Subst Abuse Treat Prev Policy.
2019;14(1):17.
16.Jafarnejad A, Khanjani N, Tirgari B. Factors
Associated with Addiction in Children in Kerman
City. J Commun Health Res 2017;6(3):175-84.
17.Heydari ST, Vossoughi M, Akbarzadeh A, Lankarani
KB, Sarikhani Y, Javanmardi K, et al. Prevalence and
risk factors of alcohol and substance abuse among
motorcycle drivers in Fars province, Iran. Chin J
Traumatol. 2016;19(02):79-84.
18.Jones DS, Podolsky SH, Greene JA. The burden of
disease and the changing task of medicine. N Engl J
Med. 2012;366(25):2333-8.
19.Shield K, Manthey J, Rylett M, Probst C, Wettlaufer
A, Parry CD, et al. National, regional, and global
burdens of disease from 2000 to 2016 attributable to
alcohol use: a comparative risk assessment study.
Lancet Public Health. 2020;5(1):e51-e61.
20.Rostam‐Abadi Y, Gholami J, Shadloo B,
Mohammad Aghaei A, Mardaneh Jobehdar M,
Ardeshir M, et al. Alcohol use, alcohol use disorder
and heavy episodic drinking in the Eastern
Mediterranean region: A systematic review. Addict.
2024;119(6):984-97.21.WHO. Harmful use of alcohol: World Health
Organization; 2024 [cited 2024 10/19/2024].
Available from:
https://www.emro.who.int/noncommunicablediseases/causes/harmful-use-of-alcohol.html.
22.WHO. Global status report on alcohol and health
2018. Geneva: World Health Organization; 2018.
23.GBD. Global, regional, and national comparative
risk assessment of 84 behavioural, environmental and
occupational, and metabolic risks or clusters of risks
for 195 countries and territories, 1990–2017: a
systematic analysis for the Global Burden of Disease
Study 2017. Lancet. 2018;392(10159):1923-94.
24.GBD. Health system performance in Iran: a
systematic analysis for the Global Burden of Disease
Study 2019. Lancet. 2022;399(10335):1625-45.
25.Aghenitei M, Galateanu OE. Global Drug Addiction.
EIRP Proceedings. 2023;18(1):473-88.
26.Masoudkabir F, Shafiee A, Heidari A, Mohammadi
NSH, Tavakoli K, Jalali A, et al. Epidemiology of
substance and opium use among adult residents of
Tehran; a comprehensive report from Tehran cohort
study (TeCS). BMC psychiatry. 2024;24(1):132.
27.Momtazi S, Rawson R. Substance abuse among
Iranian high school students. Curr Opin Psychiatry.
2010;23(3):221-6.
28.Sepanlou SG, Parsaeian M, Krohn KJ, Afshin A,
Farzadfar F, Roshandel G, et al. Disability-adjusted
life-years (DALYs) for 315 diseases and injuries and
healthy life expectancy (HALE) in Iran and its
neighboring countries, 1990–2015: Findings from
Global Burden of Disease Study 2015. Arch Iran Med.
2017;20(7):403-18.
29.Naghavi M, Abolhassani F, Pourmalek F, Moradi
Lakeh M, Jafari N, Vaseghi S, et al. The burden of
disease and injury in Iran 2003. Popul Health Metr.
2009;7:1-21.
مجله علوم پزشکی پارس